Fabricator: Dragon Pharma, Europe
Unit: x1 vial
Strength: 10 mg/ml
If your order hasn’t arrived within 35 days after shipping, we’ll resend it for free.
Discover Dragon Pharma PT-141 (Bremelanotide), a synthetic melanocortin receptor agonist studied in laboratory settings for cellular signaling and receptor modulation. Widely used in peptide research, it provides insights into melanocortin pathways.
Full Name: PT-141 (Bremelanotide)
Manufacturer/Brand: Dragon Pharma
Product Type: Research peptide
Research Relevance: Studied for melanocortin receptor signaling, neuropeptide pathways, and preclinical cellular models.
PT-141 peptide acts as a melanocortin receptor agonist, engaging MC1R and MC4R pathways. In laboratory research, it modulates cellular signaling cascades related to cyclic AMP and GPCR-mediated responses, offering a model to study neuropeptide activity.
Typical laboratory concentrations range from low nanomolar to micromolar levels. Store lyophilized peptide at 20°C. Reconstituted solutions should be handled according to lab safety protocols. For research purposes only. Not for human use.
PT-141 is a synthetic peptide used in laboratory research to study melanocortin receptor signaling and neuropeptide pathways.
Dragon Pharma produces PT-141 as a research peptide for preclinical studies.
It is used to study melanocortin receptor modulation, GPCR signaling, and cellular responses in preclinical models.
Store at 20°C and handle reconstituted solutions following laboratory safety guidelines.
PT-141 is for laboratory research purposes only.
Please log in to write PT-141 review.